Middlebrook Pharmaceuticals Inc.
Symbol:
MBRK
Exchange:
Nasdaq
Industry:
Healthcare
Products:
Drugs
Company Website: Click Here
Company Info: Click Here
Quote and News: Click Here
Profiled Price:
$1.07
(September 04)
Company Snapshot:
MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook’s proprietary delivery technology - PULSYS - enables the pulsatile delivery, or delivery in rapid bursts, of certain drugs. MiddleBrook’s near-term corporate strategy includes improving dosing regimens and/or reducing frequency of dosing to enhance patient dosing convenience and compliance for antibiotics that have been used and trusted by physicians and patients for decades. MiddleBrook currently markets KEFLEX (cephalexin, USP), the immediate-release brand of cephalexin, and MOXATAG – the first and only FDA-approved once-daily amoxicillin.
|
